Delaware | 1-815 | 51-0014090 | ||
(State or Other Jurisdiction | (Commission | (I.R.S. Employer | ||
Of Incorporation) | File Number) | Identification No.) |
E. I. DU PONT DE NEMOURS AND COMPANY | |
(Registrant) | |
/s/ Barry J. Niziolek | |
Barry J. Niziolek | |
Vice President and Controller |
Exhibit 99.1 | |||||
April 17, 2014 | Media Contact: | Patty Seif | |||
WILMINGTON, Del. | 302-774-4482 | ||||
patricia.r.seif@dupont.com | |||||
Investor Contact: | 302-774-4994 |
• | Substantial earnings increases and operating margin improvement across most segments including: Safety & Protection; Electronics & Communications; Nutrition & Health; and Industrial Biosciences. |
• | Strong sales volume growth outside the Americas. Combined European and Asian developing markets volume up 10 percent; Europe, Middle East, & Africa volumes up 6 percent. Volume growth in the Americas constrained by shifts in timing and planted area in agriculture and the impact of harsh weather. |
• | Adverse weather conditions reduced first quarter earnings by an estimated $.07 per share reflecting increased operating costs and lost sales. |
• | Productivity initiatives, share repurchase program and Performance Chemicals separation remain on track. |
• | The company reaffirms full-year operating earnings guidance of $4.20 to $4.45 per share. |
Three Months Ended | |||||||||||||||||||
March 31, 2014 | Percentage Change Due to: | ||||||||||||||||||
(Dollars in millions) | $ | % Change | Local Price | Currency Effect | Volume | Portfolio/ Other | |||||||||||||
U.S. & Canada | $ | 4,456 | (8 | ) | — | — | (7 | ) | (1 | ) | |||||||||
EMEA* | 2,952 | 8 | 1 | 1 | 6 | — | |||||||||||||
Asia Pacific | 1,749 | — | (3 | ) | (3 | ) | 6 | — | |||||||||||
Latin America | 971 | (10 | ) | (1 | ) | (4 | ) | (5 | ) | — | |||||||||
Total Consolidated Sales | $ | 10,128 | (3 | ) | (1 | ) | (1 | ) | (1 | ) | — | ||||||||
* Europe, Middle East & Africa |
Three Months Ended | Percentage Change | |||||||||||||||
SEGMENT SALES | March 31, 2014 | Due to: | ||||||||||||||
(Dollars in millions) | $ | % Change | USD Price | Volume | Portfolio/Other | |||||||||||
Agriculture | $ | 4,394 | (6 | ) | 1 | (7 | ) | — | ||||||||
Electronics & Communications | 580 | (6 | ) | (12 | ) | 6 | — | |||||||||
Industrial Biosciences | 301 | 4 | (1 | ) | 5 | — | ||||||||||
Nutrition & Health | 861 | (1 | ) | (1 | ) | — | — | |||||||||
Performance Chemicals | 1,532 | (3 | ) | (7 | ) | 6 | (2 | ) | ||||||||
Performance Materials | 1,593 | 2 | — | 2 | — | |||||||||||
Safety & Protection | 947 | 4 | (1 | ) | 5 | — | ||||||||||
Other | 1 | — | ||||||||||||||
Total segment sales | 10,209 | |||||||||||||||
Elimination of transfers | (81 | ) | ||||||||||||||
Consolidated net sales | $ | 10,128 |
Change vs. 2013 | |||||||||||||||
(Dollars in millions) | 1Q14 | 1Q13 | $ | % | |||||||||||
Agriculture | $ | 1,442 | $ | 1,516 | $ | (74 | ) | -5 | % | ||||||
Electronics & Communications | 75 | 49 | 26 | 53 | % | ||||||||||
Industrial Biosciences | 56 | 41 | 15 | 37 | % | ||||||||||
Nutrition & Health | 93 | 76 | 17 | 22 | % | ||||||||||
Performance Chemicals | 200 | 251 | (51 | ) | -20 | % | |||||||||
Performance Materials | 299 | 292 | 7 | 2 | % | ||||||||||
Safety & Protection | 175 | 138 | 37 | 27 | % | ||||||||||
Other | (92 | ) | (87 | ) | (5 | ) | nm | ||||||||
Total segment operating earnings (1) | 2,248 | 2,276 | (28 | ) | -1 | % | |||||||||
Exchange gains & losses (2) | $ | (96 | ) | $ | 11 | $ | (107 | ) | nm | ||||||
Corporate expenses | (201 | ) | (214 | ) | 13 | nm | |||||||||
Interest expense | (103 | ) | (117 | ) | 14 | nm | |||||||||
Operating earnings before income taxes | 1,848 | 1,956 | (108 | ) | -6 | % | |||||||||
Provision for income taxes on operating earnings | (370 | ) | (490 | ) | 120 | nm | |||||||||
Net income attributable to noncontrolling interests | (6 | ) | (7 | ) | 1 | nm | |||||||||
Operating earnings | $ | 1,472 | $ | 1,459 | $ | 13 | 1 | % | |||||||
Operating earnings per share | $ | 1.58 | $ | 1.56 | $ | 0.02 | 1 | % | |||||||
(1) See Schedules B and C for listing of significant items and their impact by segment. | |||||||||||||||
(2) See Schedule D for additional information on exchange gains and losses. |
SCHEDULE A | |||||||
Three Months Ended March 31, | |||||||
2014 | 2013 | ||||||
Net sales | $ | 10,128 | $ | 10,408 | |||
Other income, net | 17 | 92 | |||||
Total | 10,145 | 10,500 | |||||
Cost of goods sold | 6,000 | 6,193 | |||||
Other operating charges (a) | 797 | 912 | |||||
Selling, general and administrative expenses | 925 | 983 | |||||
Research and development expense | 518 | 521 | |||||
Interest expense | 103 | 117 | |||||
Total | 8,343 | 8,726 | |||||
Income from continuing operations before income taxes | 1,802 | 1,774 | |||||
Provision for income taxes on continuing operations (a) | 357 | 387 | |||||
Income from continuing operations after income taxes | 1,445 | 1,387 | |||||
Income from discontinued operations after taxes | — | 1,968 | |||||
Net income | 1,445 | 3,355 | |||||
Less: Net income attributable to noncontrolling interests | 6 | 7 | |||||
Net income attributable to DuPont | $ | 1,439 | $ | 3,348 | |||
Basic earnings per share of common stock (b): | |||||||
Basic earnings per share of common stock from continuing operations | $ | 1.56 | $ | 1.48 | |||
Basic earnings per share of common stock from discontinued operations | — | 2.12 | |||||
Basic earnings per share of common stock | $ | 1.56 | $ | 3.60 | |||
Diluted earnings per share of common stock (b): | |||||||
Diluted earnings per share of common stock from continuing operations | $ | 1.54 | $ | 1.47 | |||
Diluted earnings per share of common stock from discontinued operations | — | 2.10 | |||||
Diluted earnings per share of common stock | $ | 1.54 | $ | 3.58 | |||
Dividends per share of common stock | $ | 0.45 | $ | 0.43 | |||
Average number of shares outstanding used in earnings per share (EPS) calculation: | |||||||
Basic | 923,461,000 | 928,348,000 | |||||
Diluted | 930,732,000 | 935,390,000 | |||||
(a) See Schedule B for detail of significant items. | |||||||
(b) The sum of the individual earnings per share amounts may not equal the total due to rounding. |
Reconciliation of Non-GAAP Measures | ||||||||||||
Summary of Earnings Comparison | ||||||||||||
Three Months Ended March 31, | ||||||||||||
2014 | 2013 | % Change | ||||||||||
Income from continuing operations after income taxes (GAAP) | $ | 1,445 | $ | 1,387 | 4 | % | ||||||
Less: Significant items (charge) benefit included in income from continuing operations after income taxes (per Schedule B) | (12 | ) | 20 | |||||||||
Non-operating pension/OPEB costs included in income from continuing operations after income taxes | (21 | ) | (99 | ) | ||||||||
Net income attributable to noncontrolling interest | 6 | 7 | ||||||||||
Operating earnings | $ | 1,472 | $ | 1,459 | 1 | % | ||||||
EPS from continuing operations (GAAP) | $ | 1.54 | $ | 1.47 | 5 | % | ||||||
Significant items (charge) benefit included in EPS (per Schedule B) | (0.01 | ) | 0.02 | |||||||||
Non-operating pension/OPEB costs included in EPS | (0.03 | ) | (0.11 | ) | ||||||||
Operating EPS | $ | 1.58 | $ | 1.56 | 1 | % |
SCHEDULE A (continued) | ||||||||
March 31, 2014 | December 31, 2013 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 3,782 | $ | 8,941 | ||||
Marketable securities | 67 | 145 | ||||||
Accounts and notes receivable, net | 8,040 | 6,047 | ||||||
Inventories | 7,610 | 8,042 | ||||||
Prepaid expenses | 338 | 206 | ||||||
Deferred income taxes | 795 | 775 | ||||||
Assets held for sale | 202 | 228 | ||||||
Total current assets | 20,834 | 24,384 | ||||||
Property, plant and equipment, net of accumulated depreciation (March 31, 2014- $19,626; December 31, 2013 - $19,438) | 13,003 | 12,993 | ||||||
Goodwill | 4,698 | 4,713 | ||||||
Other intangible assets | 4,975 | 5,096 | ||||||
Investment in affiliates | 987 | 1,011 | ||||||
Deferred income taxes | 2,394 | 2,353 | ||||||
Other assets | 909 | 949 | ||||||
Total | $ | 47,800 | $ | 51,499 | ||||
Liabilities and Equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 3,905 | $ | 5,180 | ||||
Short-term borrowings and capital lease obligations | 2,019 | 1,721 | ||||||
Income taxes | 347 | 247 | ||||||
Other accrued liabilities | 4,814 | 6,219 | ||||||
Total current liabilities | 11,085 | 13,367 | ||||||
Long-term borrowings and capital lease obligations | 9,298 | 10,741 | ||||||
Other liabilities | 10,032 | 10,179 | ||||||
Deferred income taxes | 943 | 926 | ||||||
Total liabilities | 31,358 | 35,213 | ||||||
Commitments and contingent liabilities | ||||||||
Stockholders' equity | ||||||||
Preferred stock | 237 | 237 | ||||||
Common stock, $0.30 par value; 1,800,000,000 shares authorized; Issued at March 31, 2014 - 1,004,738,000; December 31, 2013 - 1,014,027,000) | 301 | 304 | ||||||
Additional paid-in capital | 10,880 | 11,072 | ||||||
Reinvested earnings | 17,091 | 16,784 | ||||||
Accumulated other comprehensive loss | (5,402 | ) | (5,441 | ) | ||||
Common stock held in treasury, at cost (87,041,000 shares at March 31, 2014 and December 31, 2013) | (6,727 | ) | (6,727 | ) | ||||
Total DuPont stockholders' equity | 16,380 | 16,229 | ||||||
Noncontrolling interests | 62 | 57 | ||||||
Total equity | 16,442 | 16,286 | ||||||
Total | $ | 47,800 | $ | 51,499 |
SCHEDULE A (continued) | |||||||
Three Months Ended March 31, | |||||||
2014 | 2013 | ||||||
Total Company | |||||||
Net income | $ | 1,445 | $ | 3,355 | |||
Adjustments to reconcile net income to cash used for operating activities: | |||||||
Depreciation | 312 | 327 | |||||
Amortization | 125 | 106 | |||||
Other operating charges and credits - net | 313 | (23 | ) | ||||
Gain on sale of business | — | (2,683 | ) | ||||
Contributions to pension plans | (101 | ) | (110 | ) | |||
Change in operating assets and liabilities - net | (4,515 | ) | (3,639 | ) | |||
Cash used for operating activities | (2,421 | ) | (2,667 | ) | |||
Investing activities | |||||||
Purchases of property, plant and equipment | (320 | ) | (321 | ) | |||
Investments in affiliates | (22 | ) | (18 | ) | |||
Proceeds from sale of business - net | — | 4,815 | |||||
Proceeds from sales of assets - net | 7 | 83 | |||||
Net decrease in short-term financial instruments | 80 | 99 | |||||
Forward exchange contract settlements | 15 | (47 | ) | ||||
Other investing activities - net | 4 | (3 | ) | ||||
Cash (used for) provided by investing activities | (236 | ) | 4,608 | ||||
Financing activities | |||||||
Dividends paid to stockholders | (420 | ) | (405 | ) | |||
Net (decrease) increase in borrowings | (1,127 | ) | 1,558 | ||||
Repurchase of common stock | (1,061 | ) | (1,000 | ) | |||
Proceeds from exercise of stock options | 153 | 117 | |||||
Other financing activities - net | (14 | ) | 61 | ||||
Cash (used for) provided by financing activities | (2,469 | ) | 331 | ||||
Effect of exchange rate changes on cash | (33 | ) | (96 | ) | |||
(Decrease) increase in cash and cash equivalents | (5,159 | ) | 2,176 | ||||
Cash and cash equivalents at beginning of period | 8,941 | 4,379 | |||||
Cash and cash equivalents at end of period | $ | 3,782 | $ | 6,555 | |||
Reconciliation of Non-GAAP Measure | |||||||
Calculation of Free Cash Flow - Total Company | |||||||
Three Months Ended March 31, | |||||||
2014 | 2013 | ||||||
Cash used for operating activities | $ | (2,421 | ) | $ | (2,667 | ) | |
Purchases of property, plant and equipment | (320 | ) | (321 | ) | |||
Free cash flow | $ | (2,741 | ) | $ | (2,988 | ) |
SCHEDULE B | ||||||||||||||||||||||||
SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS | ||||||||||||||||||||||||
Pre-tax | After-tax | ($ Per Share) | ||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | 2014 | 2013 | |||||||||||||||||||
1st Quarter | ||||||||||||||||||||||||
Separation transaction costs (a) | $ | (16 | ) | $ | — | $ | (12 | ) | $ | — | $ | (0.01 | ) | $ | — | |||||||||
Customer claims charge (b) | — | (35 | ) | — | (22 | ) | — | (0.02 | ) | |||||||||||||||
Income tax items (c) | — | — | — | 42 | — | 0.04 | ||||||||||||||||||
1st Quarter - Total | $ | (16 | ) | $ | (35 | ) | $ | (12 | ) | $ | 20 | $ | (0.01 | ) | $ | 0.02 | ||||||||
(a) | First quarter 2014 included a charge of $(16) recorded in Other operating charges associated with transaction costs related to the separation of the Performance Chemicals segment. For full-year 2014, costs associated with the separation are expected to be approximately $(170), $(0.13) per share. | |||||||||||||||||||||||
(b) | First quarter 2013 included a charge of $(35) recorded in Other operating charges associated with resolving claims related to the use of the Imprelis® herbicide. The company has an applicable insurance program with a deductible equal to the first $100 of costs and expenses. The insurance program limits are $725 for costs and expenses in excess of the $100. The company has submitted and will continue to submit requests for payment to its insurance carriers for costs associated with this matter. To date, the company has received $73 of insurance recoveries from its insurance carriers and continues to seek recovery although the timing and outcome remain uncertain. The company had accruals of $426 related to these claims at March 31, 2014. These charges relate to the Agriculture segment. | |||||||||||||||||||||||
(c) | First quarter 2013 included a net tax benefit of $42 consisting of a $68 benefit for the 2013 extension of certain U.S business tax provisions offset by a ($26) charge related to the global distribution of Performance Coatings cash proceeds. | |||||||||||||||||||||||
SCHEDULE C | |||||||||
Three Months Ended March 31, | |||||||||
SEGMENT SALES (1) | 2014 | 2013 | |||||||
Agriculture | $ | 4,394 | $ | 4,669 | |||||
Electronics & Communications | 580 | 616 | |||||||
Industrial Biosciences | 301 | 289 | |||||||
Nutrition & Health | 861 | 868 | |||||||
Performance Chemicals | 1,532 | 1,585 | |||||||
Performance Materials | 1,593 | 1,559 | |||||||
Safety & Protection | 947 | 907 | |||||||
Other | 1 | 1 | |||||||
Total Segment sales | 10,209 | 10,494 | |||||||
Elimination of transfers | (81 | ) | (86 | ) | |||||
Consolidated net sales | $ | 10,128 | $ | 10,408 | |||||
(1) Sales for the reporting segments include transfers. | |||||||||
SCHEDULE C (continued) | ||||||||||
Three Months Ended March 31, | ||||||||||
INCOME FROM CONTINUING OPERATIONS (GAAP) | 2014 | 2013 | ||||||||
Agriculture | $ | 1,442 | $ | 1,481 | ||||||
Electronics & Communications | 75 | 49 | ||||||||
Industrial Biosciences | 56 | 41 | ||||||||
Nutrition & Health | 93 | 76 | ||||||||
Performance Chemicals | 200 | 251 | ||||||||
Performance Materials | 299 | 292 | ||||||||
Safety & Protection | 175 | 138 | ||||||||
Other | (92 | ) | (87 | ) | ||||||
Total Segment PTOI | 2,248 | 2,241 | ||||||||
Corporate expenses | (217 | ) | (214 | ) | ||||||
Interest expense | (103 | ) | (117 | ) | ||||||
Non-operating pension/OPEB costs | (30 | ) | (147 | ) | ||||||
Net exchange (losses) gains (1) | (96 | ) | 11 | |||||||
Income before income taxes from continuing operations | $ | 1,802 | $ | 1,774 | ||||||
Three Months Ended March 31, | ||||||||||
SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (2) | 2014 | 2013 | ||||||||
Agriculture | $ | — | $ | (35 | ) | |||||
Electronics & Communications | — | — | ||||||||
Industrial Biosciences | — | — | ||||||||
Nutrition & Health | — | — | ||||||||
Performance Chemicals | — | — | ||||||||
Performance Materials | — | — | ||||||||
Safety & Protection | — | — | ||||||||
Other | — | — | ||||||||
Total significant items by segment | — | (35 | ) | |||||||
Corporate expenses | (16 | ) | — | |||||||
Total significant items before income taxes | $ | (16 | ) | $ | (35 | ) | ||||
Three Months Ended March 31, | ||||||||||
OPERATING EARNINGS | 2014 | 2013 | ||||||||
Agriculture | $ | 1,442 | $ | 1,516 | ||||||
Electronics & Communications | 75 | 49 | ||||||||
Industrial Biosciences | 56 | 41 | ||||||||
Nutrition & Health | 93 | 76 | ||||||||
Performance Chemicals | 200 | 251 | ||||||||
Performance Materials | 299 | 292 | ||||||||
Safety & Protection | 175 | 138 | ||||||||
Other | (92 | ) | (87 | ) | ||||||
Total segment operating earnings | 2,248 | 2,276 | ||||||||
Corporate expenses | (201 | ) | (214 | ) | ||||||
Interest expense | (103 | ) | (117 | ) | ||||||
Operating earnings before income taxes and exchange gains (losses) | 1,944 | 1,945 | ||||||||
Net exchange (losses) gains (1) | (96 | ) | 11 | |||||||
Operating earnings before income taxes | $ | 1,848 | $ | 1,956 | ||||||
(1) See Schedule D for additional information on exchange gains and losses. | ||||||||||
(2) See Schedule B for detail of significant items. |
SCHEDULE D | ||||||||||
Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements | ||||||||||
Three Months Ended March 31, | ||||||||||
2014 | 2013 | |||||||||
Income from continuing operations before income taxes | $ | 1,802 | $ | 1,774 | ||||||
Add: Significant items before income taxes | 16 | 35 | ||||||||
Add: Non-operating pension/OPEB costs | 30 | 147 | ||||||||
Operating earnings before income taxes | $ | 1,848 | $ | 1,956 | ||||||
Less: Net income attributable to noncontrolling interests | 6 | 7 | ||||||||
Add: Interest expense | 103 | 117 | ||||||||
Adjusted EBIT from operating earnings | 1,945 | 2,066 | ||||||||
Add: Depreciation and amortization | 437 | 433 | ||||||||
Adjusted EBITDA from operating earnings | $ | 2,382 | $ | 2,499 | ||||||
Reconciliation of Operating Earnings Per Share (EPS) Outlook | ||||||||||
The reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings from continuing operations excluding significant items and non-operating pension/OPEB costs. | ||||||||||
Year Ended December 31, | ||||||||||
2014 Outlook | 2013 Actual | |||||||||
Operating EPS | $4.20 - $4.45 | $ | 3.88 | |||||||
Significant items | ||||||||||
Separation transaction costs | (0.13 | ) | ||||||||
Tax items | 0.02 | |||||||||
Customer claims charges | (0.24 | ) | ||||||||
Restructuring charge/adjustments | — | |||||||||
Litigation settlement | (0.05 | ) | ||||||||
Asset impairment charge | (0.18 | ) | ||||||||
Non-operating pension/OPEB costs - estimate | (0.09 | ) | (0.39 | ) | ||||||
EPS from continuing operations (GAAP) | $3.98 - $4.23 | $ | 3.04 | |||||||
2014 Operating EPS excludes the potential gain on sale of Glass Laminating Solutions/Vinyls. |
SCHEDULE D (continued) | ||||||||
Exchange Gains/Losses on Operating Earnings | ||||||||
The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in Other income, net and the related tax impact is recorded in Provision for (benefit from) income taxes on the Consolidated Income Statements. | ||||||||
Three Months Ended March 31, | ||||||||
2014 | 2013 | |||||||
Subsidiary/Affiliate Monetary Position Gain (Loss) | ||||||||
Pre-tax exchange gains (losses) (includes equity affiliates) | $ | (50 | ) | $ | (95 | ) | ||
Local tax benefits (expenses) | 12 | 3 | ||||||
Net after-tax impact from subsidiary exchange gains (losses) | $ | (38 | ) | $ | (92 | ) | ||
Hedging Program Gain (Loss) | ||||||||
Pre-tax exchange gains (losses) | $ | (46 | ) | $ | 106 | |||
Tax benefits (expenses) | 16 | (37 | ) | |||||
Net after-tax impact from hedging program exchange gains (losses) | $ | (30 | ) | $ | 69 | |||
Total Exchange Gain (Loss) | ||||||||
Pre-tax exchange gains (losses) | $ | (96 | ) | $ | 11 | |||
Tax benefits (expenses) | 28 | (34 | ) | |||||
Net after-tax exchange gains (losses) (1) | $ | (68 | ) | $ | (23 | ) | ||
As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)." | ||||||||
(1) The above Net after-tax exchange gains (losses) excludes gains (losses) attributable to discontinued operations of $0 and $(5) for the three months ended March 31, 2014 and 2013. | ||||||||
Reconciliation of Base Income Tax Rate to Effective Income Tax Rate | ||||||||
Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), as defined above, significant items and non-operating pension/OPEB costs. | ||||||||
Three Months Ended March 31, | ||||||||
2014 | 2013 | |||||||
Income from continuing operations before income taxes | $ | 1,802 | $ | 1,774 | ||||
Add: Significant items - (benefit) charge (2) | 16 | 35 | ||||||
Non-operating pension/OPEB costs | 30 | 147 | ||||||
Less: Net exchange (losses) gains | (96 | ) | 11 | |||||
Income from continuing operations before income taxes, significant items, | ||||||||
exchange gains (losses), and non-operating pension/OPEB costs | $ | 1,944 | $ | 1,945 | ||||
Provision for income taxes on continuing operations | $ | 357 | $ | 387 | ||||
Add: Tax benefits on significant items | 4 | 55 | ||||||
Tax benefits on non-operating pension/OPEB costs | 9 | 48 | ||||||
Tax benefits on exchange gains/losses | 28 | (34 | ) | |||||
Provision for income taxes on operating earnings, excluding exchange gains (losses) | $ | 398 | $ | 456 | ||||
Effective income tax rate | 19.8 | % | 21.8 | % | ||||
Significant items effect and non-operating pension/OPEB costs effect | 0.2 | % | 3.3 | % | ||||
Tax rate, from continuing operations, before significant items and non-operating pension/OPEB costs | 20.0 | % | 25.1 | % | ||||
Exchange gains (losses) effect | 0.5 | % | (1.7 | )% | ||||
Base income tax rate from continuing operations | 20.5 | % | 23.4 | % | ||||
(2) See Schedule B for detail of significant items. |